Cargando…

What do urologists think patients need to know when starting on androgen deprivation therapy? The perspective from Canada versus countries with lower gross domestic product

BACKGROUND: Androgen deprivation therapy (ADT) side effects are numerous and negatively impact prostate cancer patients’ quality of life. There is considerable discrepancy though among Canadian urologists regarding what ADT side effects and side effect management strategies. Little is known about gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rot, Irena, Wassersug, Richard J., Walker, Lauren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837317/ https://www.ncbi.nlm.nih.gov/pubmed/27141453 http://dx.doi.org/10.21037/tau.2016.03.06

Ejemplares similares

Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer
por: Shahinian, Vahakn B, et al.
Publicado: (2015)

Statistics: The stethoscope of a thinking urologist
por: Sivanandam, Arun S.
Publicado: (2009)

When things start to think
por: Gershenfeld, Neil
Publicado: (1999)

What Is Fecal Incontinence That Urologists Need to Know?
por: Kim, HongWook, et al.
Publicado: (2021)

Staghorn renal stones: what the urologist needs to know
por: Torricelli, Fabio C. M., et al.
Publicado: (2020)

Androgen Deprivation Alters Attention to Sexually Provocative Visual Stimuli in Elderly Men
por: Palmer-Hague, Jaime L., et al.
Publicado: (2017)

An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer
por: Merseburger, Axel S., et al.
Publicado: (2016)

What should urologists know about evidence-based medicine?
por: Mazel, Jan W., et al.
Publicado: (2011)

Image-guided urological interventions: What the urologists must know
por: Das, Chandan J., et al.
Publicado: (2015)

Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers
por: Choi, Erin, et al.
Publicado: (2022)

An Educational Program to Help Patients Manage Androgen Deprivation Therapy Side Effects: Feasibility, Acceptability, and Preliminary Outcomes
por: Wibowo, Erik, et al.
Publicado: (2020)

Antiplatelet drugs and the perioperative period: What every urologist needs to know
por: Vasudeva, Pawan, et al.
Publicado: (2009)

SARS-CoV-2 tropism: what urologists need to know
por: Desouky, Elsayed
Publicado: (2021)

Genitourinary Symptoms Caused by Monkeypox Virus: What Urologists Should Know
por: Yu, Zhikang, et al.
Publicado: (2023)

Impact of malaria morbidity on gross domestic product in Uganda
por: Orem, Juliet Nabyonga, et al.
Publicado: (2012)

Chronic kidney disease and small renal tumors: What urologists should know?
por: Muruganandham, K., et al.
Publicado: (2009)

Testicular microlithiasis: what urologists should know. A review of the current literature
por: Balawender, Krzysztof, et al.
Publicado: (2018)

COVID-19: Measures to prevent hospital contagion. What do urologists need to know?
por: Castro, Edgar Ivan Bravo, et al.
Publicado: (2020)

Cardiometabolic and Skeletal Risk Factors in Black Men with Prostate Cancer Starting Androgen Deprivation Therapy
por: Gunnarsson, Orvar, et al.
Publicado: (2015)

Urosepsis and the urologist!
por: Ryan, James, et al.
Publicado: (2021)

What every urologist should know about surgical trials Part I: Are the results valid?
por: Bajammal, Sohail, et al.
Publicado: (2008)

What should urologists know about Pseudojournals and open access publishing? A narrative review of the literature
por: Jena, Rahul, et al.
Publicado: (2022)

The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers—What Should a Urologist Really Know?
por: Malinaric, Rafaela, et al.
Publicado: (2022)

US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
por: Al Saffar, Haidar, et al.
Publicado: (2023)

Contribution of clinical trials to gross domestic product in Hungary
por: Kaló, Zoltán, et al.
Publicado: (2014)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Experimental subjects do not know what we think they know
por: Field, Jared M., et al.
Publicado: (2020)

How I Built My Personal, Patient-Centered Health Care Team: Instead of Doctors, I Started With Students
por: Wassersug, Richard
Publicado: (2023)

Pathology Update for Urologists
por: Iczkowski, Kenneth A., et al.
Publicado: (2011)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Starting over and thinking long term…
por: Bradshaw, Ralph A., et al.
Publicado: (2021)

Valuing health as development: going beyond gross domestic product
por: Fan, Victoria Y, et al.
Publicado: (2018)

Economic Complexity: Correlations between Gross Domestic Product and Fitness
por: Vinci, Gianni Valerio, et al.
Publicado: (2018)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

The clinical relevance of adiposity when assessing muscle health in men treated with androgen deprivation for prostate cancer
por: Owen, Patrick J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f0dn0ojv2d4bqahub8npvfh0ub